Exforge

Novartis to pay $245 mln to end antitrust cases over Exforge drug generics
Reuters
Thu, 01/5/23 - 09:57 am
Novartis
generics
antitrust
legal
Exforge
hypertension
5 Blockbuster Drugs Going Off Patent in 2014
Motley Fool
Wed, 12/4/13 - 08:38 am
patents
Eli Lilly
Evista
Teva
Copaxone
Novartis
Exforge
Sandostatin LAR
Nexium
AstraZeneca
Top 10 Drug Patent Losses of 2014
Fierce Pharma
Mon, 10/28/13 - 10:26 am
patents
Copaxone
Teva
Nexium
AstraZeneca
Micardis
Boehringer Ingelheim
Sandostatin LAR
Novartis
Exforge
Nasonex
Merck
TriLipix
AbbVie
Evista
Eli Lilly
Restasis
Allergan
Renagel
Sanofi
Novartis says 3 drugs approved in Japan
Yahoo/AP
Wed, 01/20/10 - 06:33 pm
Japan
Novartis
Equa
Exforge
Afinitor
Novartis Looks at Combination Pills to Fix Hypertension Franchise
BNET Pharma
Wed, 11/25/09 - 07:40 am
hypertension
Novartis
Diovan
Exforge